0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Human Health Effects Nanoplastics Remediation Sign in to save

Microplastic in perfusion: the hidden risk and how to address it

Interdisciplinary CardioVascular and Thoracic Surgery 2025 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 53 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Friedhelm Beyersdorf

Summary

This commentary addresses the emerging concern that cardiopulmonary bypass circuits and other extracorporeal circulation systems release significant levels of micro- and nanoplastics into patients during medical procedures. The authors note that the same properties making plastics ideal for medical tubing also make their degradation products potentially harmful. The study calls for further research into the clinical implications of plastic particle exposure during these increasingly common medical interventions.

of the ICVTS by Green and colleagues (1) from the University of Hull in the United Kingdom addresses an often underestimated yet increasingly recognized issue in medicine and other scientific fields: the degradation of plastic into microand nano-plastics (MNPs).This topic has garnered exponential interest in recent years, and for good reason.All forms of extracorporeal circulation rely on plastic materials for tubing and additional devices.While the chemical stability of these materialscharacterized by strong polymer bonds, hydrophobic properties, and crystalline structuresmakes them ideal for medical use, these very qualities now pose potential health risks.With an annual global plastic production of 400 million tons, projected to double by 2050 (2, 3), the environmental and biological impact of plastic degradation products has become a pressing concern.Micro-and nanoplastic particles are now pervasive in the air, water, and food supply, and have been detected in all living organismsincluding human organs.Against this backdrop, it is unsurprising that Green et al. ( 1) report significant levels of microplastic generation from cardiopulmonary bypass circuits.The key questions now are: How should these findings be interpreted, and what challengesbut also opportunitiesdo they present for future research and clinical practice (4)? Expanding Applications of Extracorporeal Circulation Techniques in the Coming Decade

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Microplastics in cardiopulmonary bypass: quantification and characterization of particles across systems

Researchers measured microplastic contamination generated by cardiopulmonary bypass machines used during heart surgery and found significant levels of plastic particles across the systems tested. The study characterized the types and quantities of microplastics produced during machine operation. The findings raise questions about patient exposure to microplastics during cardiac procedures and highlight the need for further research into whether these particles have clinical significance.

Article Tier 2

Microplastics in cardiopulmonary bypass: quantification and characterisation of particles across systems

Researchers quantified microplastics generated during conventional and minimally invasive cardiopulmonary bypass circuits in vitro, finding that both systems shed detectable MPs into circulating fluid, with particle characteristics varying between circuit designs.

Article Tier 2

Micronanoplastic exposure due to cardiopulmonary bypass in children: A prospective observational study.

A prospective observational study in children undergoing cardiac surgery with cardiopulmonary bypass (CPB) found measurable levels of micronanoplastics (MNPs) in blood samples collected after bypass. The study demonstrated that CPB circuits made of plastic components release MNPs directly into the bloodstream during surgery.

Article Tier 2

Medical exposure to micro(nano)plastics: An exposure pathway with potentially significant harm to human health that should not be overlooked.

This paper identifies medical procedures — including intravenous infusions, dialysis, and surgical implants — as an underrecognized pathway for direct human exposure to micro- and nano-plastics. The authors argue that the medical community needs to assess and reduce plastic particle exposure from clinical materials and devices.

Article Tier 2

Spallation and particles infusion into the extracorporeal circuit during CRRT: a preventable phenomenon

Researchers found that plastic tubing and fluid bags used in continuous kidney replacement therapy (CRRT) shed tiny plastic microparticles directly into patients' bloodstreams during treatment. Adding in-line filters to the circuit reduced this particle load, suggesting a practical way to protect critically ill patients from unintended plastic exposure during life-saving procedures.

Share this paper